Related Experiment Video
Updated: Feb 8, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1
Huiqin Hu1, Li Yang1, Lijun Li2
1Department of Chinese Medicine, Affiliated Longhua Central Hospital, Guangdong Medical University, Shenzhen, 518110, Guangdong, China.
Abstract:
The underlying functions of long non-coding RNAs (lncRNAs) on chemoresistance in multiple cancers have been testified. However, the function and mechanism of lncRNAs on chemoresistance in hepatocellular carcinoma are still confused. In this study, we concentrated on the function and mechanism of KCNQ1OT1 on oxaliplatin resistance in hepatocellular carcinoma. Results showed that KCNQ1OT1 was significantly up-regulated in oxaliplatin-resistant HepG2 and Huh7 cells. Moreover, knockdown of KCNQ1OT1 inhibited the cell proliferation, migration, invasion and reduced the expression of drug-resistant gene (MRP5, MDR1, LRP1). Additionally, bioinformatics analysis and dual-luciferase reporter assay showed that miR-7-5p directly targeted the 3'-UTR of miR-7-5p and ABCC1 mRNA, indicating that KCNQ1OT1 regulated the expression of ABCC1 via endogenous sponging miR-7-5p. Conclusively, KCNQ1OT1 modulated oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis, indicating a novel approach for the treatment of hepatocellular carcinoma.
Insights
Long non-coding RNA KCNQ1OT1 promotes oxaliplatin resistance in hepatocellular carcinoma by regulating the miR-7-5p/ABCC1 axis. Targeting this pathway offers a potential new treatment strategy for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play roles in cancer chemoresistance.
- The specific mechanisms of lncRNAs in hepatocellular carcinoma (HCC) chemoresistance remain unclear.
Purpose of the Study:
- To investigate the function and mechanism of KCNQ1OT1 in oxaliplatin resistance in HCC.
- To explore the KCNQ1OT1/miR-7-5p/ABCC1 regulatory axis in HCC chemoresistance.
Main Methods:
- Quantitative real-time PCR to detect KCNQ1OT1 expression.
- Cell proliferation, migration, and invasion assays.
- Bioinformatics analysis and dual-luciferase reporter assays to confirm target interactions.
Main Results:
- KCNQ1OT1 was significantly upregulated in oxaliplatin-resistant HCC cells (HepG2, Huh7).
- KCNQ1OT1 knockdown inhibited proliferation, migration, and invasion, and reduced drug-resistant gene expression (MRP5, MDR1, LRP1).
- KCNQ1OT1 sponges miR-7-5p, regulating ABCC1 expression via the miR-7-5p/ABCC1 axis.
Conclusions:
- KCNQ1OT1 promotes oxaliplatin resistance in HCC through the miR-7-5p/ABCC1 pathway.
- This axis represents a potential therapeutic target for HCC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Hypothalamic-Pituitary Axis
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Nursing Code of Ethics

